AGN 3.51% 88.5¢ argenica therapeutics limited

Ann: AGM Presentation, page-2

  1. 9,810 Posts.
    lightbulb Created with Sketch. 971
    Great presentation.

    There is always a slight upgrade to each presentation.

    My suggestion to the company is after Phase 1 trial results is to raise $40 mil at $2 a share and lets go straight into Phase 2 for :

    Stroke - which is a given and also :

    HIE
    TBI and concussion
    Surgically induced stroke

    and Alzheimers

    A multi pronged Phase 2 for a huge unmet need
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.